SINSIN PHARMACEUTICAL Co., LTD.
002800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002800001
- LEI:
- Country:
- South Korea
- Address:
- 세종특별자치시 소정면 소정산단동로 9 -, 세종특별자치시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 26.2 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.9 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 24.5 KB | ||
| 2025-03-18 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 418.8 KB | ||
| 2025-03-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 119.4 KB | ||
| 2025-03-11 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 114.8 KB | ||
| 2025-02-05 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.2 KB | ||
| 2025-02-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.8 KB | ||
| 2025-01-22 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.2 KB | ||
| 2025-01-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2025-01-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-12-12 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all SINSIN PHARMACEUTICAL Co., LTD. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SINSIN PHARMACEUTICAL Co., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SINSIN PHARMACEUTICAL Co., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX
United States of America
ENTX
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
United States of America
ENTO
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
United States of America
TRDA
South Korea
183490
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Sweden
ENZY
Develops ingestible therapeutic devices for weight management and targeted drug delivery.
Israel
EPIT
Israel
EPIT
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Sweden
EQL
Clinical-stage oncology company developing therapies targeting the RAS/MAPK pathway in cancer.
United States of America
ERAS
United States of America
ERAS
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
United States of America
ERNA
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP
France
ERYP